Lymphangiomatosis is a rare disease characterized by diffuse infiltration of lymphangiomas in the lung, bone, and other tissues. Due to its rarity, the spectrum of lymphangiomatosis is beginning to be elucidated based on case reports. The limited pathological, radiological, and clinical studies have shed light on this disease. Treatments have been tested in unblinded manner with promising results; however, further understanding of the pathogenesis of disease, as well as its natural history, is needed to facilitate drug development.
Get full access to this article
View all access options for this article.
References
1.
FaulJLet al.Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med, 2000; 161:1037–1046.
2.
HilliardRI, McKendryJB, PhillipsMJ. Congenital abnormalities of the lymphatic system: A new clinical classification. Pediatrics, 1990; 86:988–994.
de LimaASet al.Pulmonary lymphangiomatosis: A report of two cases. J Bras Pneumol, 2007; 33:229–233.
7.
DuMHet al.Diffuse pulmonary lymphangiomatosis: A case report with literature review. Chin Med J (Engl), 2011; 124:797–800.
8.
TranD, FallatME, BuchinoJJ. Lymphangiomatosis: A case report. South Med J, 2005; 98:669–671.
9.
RadhakrishnanK, RocksonSG. The clinical spectrum of lymphatic disease. Ann NY Acad Sci, 2008; 1131:155–184.
10.
AvivRI, McHughK, HuntJ. Angiomatosis of bone and soft tissue: A spectrum of disease from diffuse lymphangiomatosis to vanishing bone disease in young patients. Clin Radiol, 2001; 56:184–190.
11.
FukahoriSet al.Thoracic lymphangiomatosis with massive chylothorax after a tumor biopsy and with disseminated intravenous coagulation—Lymphoscintigraphy, an alternative minimally invasive imaging technique: Report of a case. Surg Today, 2011; 41:978–982.
12.
WunderbaldingerPet al.CT and MR imaging of generalized cystic lymphangiomatosis in pediatric patients. AJR Am J Roentgenol, 2000; 174:827–832.
13.
TamayZet al.Diffuse thoracic lymphangiomatosis with disseminated intravascular coagulation in a child. J Pediatr Hematol Oncol, 2005; 27:685–687.
14.
Taveira-DaSilvaAM, Pacheco-RodriguezG, MossJ. The natural history of lymphangioleiomyomatosis: Markers of severity, rate of progression and prognosis. Lymphat Res Biol, 2010; 8:9–19.
15.
HolthoferHet al.Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest, 1982; 47:60–66.
16.
AlitaloK, TammelaT, PetrovaTV. Lymphangiogenesis in development and human disease. Nature, 2005; 438:946–953.
17.
WattsMA, GibbonsJA, AaronBL. Mediastinal and osseous lymphangiomatosis: Case report and review. Ann Thorac Surg, 1982; 34:324–328.
18.
BaulieuFet al.Visualization of the thoracic duct by lymphoscintigraphy. Eur J Nucl Med, 1987; 13:264–265.
19.
SwankDW, HepperNG, FolkertKE, ColbyTV. Intrathoracic lymphangiomatosis mimicking lymphangioleiomyomatosis in a young woman. Mayo Clin Proc, 1989; 64:1264–1268.
20.
MiettinenMet al.Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: Comparison with four other melanoma markers. Am J Surg Pathol, 2001; 25:205–211.
21.
LaverdiereCet al.Improvement of disseminated lymphangiomatosis with recombinant interferon therapy. Pediatr Pulmonol, 2000; 29:321–324.
22.
BrodszkiNet al.A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax. Acta Paediatr, 2011; 100:1448–1453.
23.
FontanesiJ. Radiation therapy in the treatment of Gorham disease. J Pediatr Hematol Oncol, 2003; 25:816–817.
24.
BordenECet al.Interferons at age 50: Past, current and future impact on biomedicine. Nat Rev Drug Discov, 2007; 6:975–990.
25.
OzekiM, FukaoT, KondoN. Propranolol for intractable diffuse lymphangiomatosis. N Engl J Med, 2011; 364:1380–1382.
